Evidence map›Paper›PMID 34950853›Full record

ArticleGeneral psychiatry2021

The cost of obsessive-compulsive disorder (OCD) in China: a multi-center cross-sectional survey based on hospitals.

Weili Yang, Zhen Tang, Xijin Wang, Xiancang Ma, Yuqi Cheng, Bin Wang, Ping Sun, Wenxin Tang, Jia Luo, Changhong Wang and 5 more

Abstract read
In one paragraph

Article in General psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Sensorimotor circuit connectivity as a candidate biomarker for responsiveness to sertraline in obsessive-compulsive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Weili YangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-2281-6073
Zhen TangSuzhou Guangji Hospital, Suzhou, Jiangsu Province, China.
Xijin WangThe First Psychiatric Hospital of Harbin, Harbin, Heilongjiang Province, China.
Xiancang MaDepartment of psychiatry, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province, China.
Yuqi ChengFirst Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China.
Bin WangShandong Provincial Hospital, Shandong First Medical University, Jinan, Shandong Province, China.
Ping SunQingdao Mental Health Center, Qingdao, Shandong Province, China.
Wenxin TangAffiliated Mental Health Center & Hangzhou Seventh People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
Jia LuoThe Department of Clinical Psychology, Beijing Anding Hospital, Capital Medical University, Beijing, China.
Changhong WangThe Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China.
Ping LiDepartment of Psychiatry, Qiqihar Medical University, Qiqihar, Heilongjiang Province, China.
Guiyun XuGuangzhou Brain Hospital Affiliated to Guangzhou Medical University, Guangzhou, Guangdong Province, China.
Jun YanPeking University Sixth Hospital, Peking University Institute of Mental Health, Peking University, Beijing, China.
Vlasios BrakouliasThe University of Sydney, Nepean Hospital, Sydney Medical School, Sydney, New South Wales, Australia.
Zhen WangShanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0003-4319-5314

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObsessive-compulsive disorder (OCD) is considered a very debilitating disorder with severe loss of quality of life and income.

aimsThis study estimates the quality of life and economic consequences of OCD in China.

methodsThe research team interviewed 639 patients with OCD in 13 hospitals in 12 cities in China. The direct method was used to get the direct cost of OCD. Indirect costs associated with OCD were estimated using the human capital approach. Linear regression analysis was conducted for quality of life and generalised linear model analysis was conducted for total cost. Sensitivity analysis was used to analyse the uncertainty of total cost.

resultsThe mean quality of life score for OCD was 52.78 (20.46). The annual total cost of OCD per capita was 24 503.78 (95% CI: 22 621.53 to 26 386.03) renminbi (RMB) (US$3465.88 (95% CI: US$3199.65 to US$3732.11)). The annual cost of OCD in China was estimated to be 37.74 billion (95% CI: 34.95 billion to 40.53 billion) RMB (equal to US$5.34 billion (95% CI: US$4.94 billion to US$5.73 billion)). Sensitivity analysis showed that the total annual cost of OCD in China was between 23.15 billion RMB (US$3.27 billion) and 370.00 billion RMB (US$52.33 billion). Worse social function status, more psychiatric symptoms and higher Yale Brown Obsessive-Compulsive Scale (Y-BOCS) score were associated with worse quality of life. The numbers of clinic visits and hospitalisations, socioeconomic status, education, Y-BOCS scores and age were found to be significantly associated with total cost.

conclusionsOCD is associated with low quality of life and high costs in China. The findings call for concerted efforts to improve services for patients with OCD.Improvements may include early detection and diagnosis, the provision of evidence-based treatments and relapse prevention strategies.

Indexed as

behaviouraleconomicsobsessive-compulsive disorder

Identifiers

PMID34950853
PMCPMC8655608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.